- Offering of 6,147,142 new shares (c. 30% of pre-deal outstanding share capital)
- Subscription price of €68.00 per share, 10.8% discount to TERP based on Euronext Brussels closing price on 23 April 2019 adjusted for pro rata dividend
- Kempen acted as Co-Lead Manager in this transaction
- Aedifica is a leading Belgian listed company investing in healthcare real estate in Germany, The Netherlands, and Belgium, particularly in terms of senior housing.
- In selecting assets, the company aims to create a portfolio which balances a recurring revenue oriented strategy with a potential for capital gains.
- Aedifica is currently in the process of orienting its asset base towards becoming a pure play healthcare real estate investor in Europe